ArticleNature. Mental health2025
A 20-year longitudinal cohort study of post-traumatic stress disorder in World Trade Center responders.
Article in Nature. Mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Nova Protocol: a comprehensive multimodal longitudinal study among civilian survivors of a mass trauma event.European journal of psychotraumatology · 2026Article
- Posttraumatic Stress Symptom Heterogeneity in World Trade Center Responders: Relations to Maladaptive Personality Traits.American journal of industrial medicine · 2026Article
- Posttraumatic Stress Dynamics and 15-Year Persistence in Great East Japan Earthquake Survivors.JAMA network open · 2026Article
- Integrated proteomic and metabolomic analyses implicate redox-metabolic pathways in PTSD-associated multisystem disease and accelerated aging.Nature communications · 2026Article
- Posttraumatic Stress Disorder and Handgrip Strength Among World Trade Center Firefighters and Emergency Medical Responders.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Post-traumatic stress disorder (PTSD) is a debilitating condition with serious implications for mental and physical health. While previous studies have documented PTSD prevalence and short-term trajectories, detailed examination of long-term symptom patterns remains limited, especially in large cohorts. This study investigates 20-year PTSD symptom trajectories in World Trade Center (WTC) responders, constituting one of the largest and longest studies of PTSD to date. We aimed to answer six questions: (1) How stable are symptoms? (2) What is the average trajectory? (3) What are atypical trajectories? (4) How quickly do symptoms improve and worsen? (5) Does symptom course differ across demographics or (6) predict functional impairments or mental health care utilization? Data include 81,298 observations from 12,822 responders. Symptoms were stable in the short term but changed significantly over two decades, peaking over a decade after exposure and declining modestly thereafter. Demographic differences in average trajectories were small. Median time before symptoms improved was 8 to 10 years for PTSD cases (median = 8.88, 95% CI = 8.01, 9.79). Most experienced improvement after a decade, but approximately 10% reported elevated symptoms two decades after trauma. Changes in symptoms predicted higher functional impairments and mental health care utilization. Our findings highlight the enduring impact of PTSD among WTC responders, with substantial variability in individual trajectories. Despite overall modest declines, a subset remained highly symptomatic, underscoring the need for continued treatment. These results emphasize the importance of long-term monitoring and highlight the need for tailored treatment strategies for trauma-exposed populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.